Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin therapy: current alternatives.

Francisco J Gómez-Pérez1, Juan A Rull

  • 1Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, México. Fcojgomezp@aol.com

Archives of Medical Research
|June 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time in range and its association with sudomotor dysfunction in individuals with type 1 diabetes mellitus.

Endocrinologia, diabetes y nutricion·2026
Same author

Impact of acromegaly subtypes on survival: results from a large multicenter cohort.

Journal of the Endocrine Society·2026
Same author

Panhypophysitis and infundibulitis associated with granulomatosis with polyangiitis.

Endocrinology, diabetes & metabolism case reports·2025
Same author

Sucralose consumption modifies glucose homeostasis, gut microbiota, Curli protein, and related metabolites in healthy individuals: A randomized placebo-controlled, triple-blind trial.

Clinical nutrition ESPEN·2025
Same author

Remission of Statin-associated Autoimmune Necrotizing Myopathy With Sequential Immunotherapy: A Well-studied Patient.

JCEM case reports·2025
Same author

Stiff Person Syndrome and Brittle Type 1 Diabetes: Report of 2 Cases.

AACE clinical case reports·2024
Same journal

Early-Life Lipid Exposure Induces Lasting Skeletal Muscle Remodeling Via Fetal Programming in Male Wistar Rats.

Archives of medical research·2026
Same journal

Peripubertal Physical Activity in Male Wistar Rats Helps to Prove the Concept of Developmental Origins of Health and Disease.

Archives of medical research·2026
Same journal

Associations between Red Blood Cell Transfusions and Health-Related Outcomes in Older Adults with Hip Fractures: A Systematic Review with Meta-Analysis.

Archives of medical research·2026
Same journal

Association of MBL2 Polymorphisms with HAM/TSP in HTLV-1 Infection: A Case-Control Study Approach.

Archives of medical research·2026
Same journal

Financial Costs of Tobacco-Attributable Temporary Sick Leave in Social Security Systems: The Case of Mexico, 2010-2022.

Archives of medical research·2026
Same journal

Access to Medicines for Rare Diseases in Brazil.

Archives of medical research·2026
See all related articles

New insulin therapies, including ultra-short/long-acting analogs and inhaled insulin, aim to mimic natural insulin secretion for better glucose control in diabetes. These advancements offer improved quality of life and potentially fewer complications.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Background:

  • Maintaining tight blood glucose and insulin control is challenging in type 1 and type 2 diabetes mellitus (DM).
  • Physiological insulin secretion patterns are difficult to replicate with current diabetes management strategies.
  • Advances in insulin therapy are crucial for improving patient outcomes and quality of life.

Purpose of the Study:

  • To review recent advancements in insulin therapy for diabetes management.
  • To explore novel insulin analogs and administration routes for improved glycemic control.
  • To assess the efficacy and safety of new insulin delivery methods, including inhaled insulin.

Main Methods:

  • Review of current literature on insulin analogs (ultra-short and ultra-long acting).

Related Experiment Videos

  • Analysis of studies on novel insulin administration routes, focusing on inhaled insulin.
  • Evaluation of data regarding glucose level profiles, hypoglycemia prevalence, and potential long-term complications.

    • Main Results:

    • Ultra-short and ultra-long-acting insulin analogs demonstrate improved glycemic control and reduced hypoglycemia.
    • Inhaled insulin shows promise for excellent glucose control with minimal short-term side effects.
    • Newer insulin therapies are enhancing the quality of life for diabetic patients.

    Conclusions:

    • Novel insulin analogs and delivery systems represent significant progress in diabetes care.
    • Inhaled insulin is a promising non-invasive option, but long-term safety data are still needed.
    • Continued research into advanced insulin therapies is essential for reducing diabetes complications.